Company Analysis
Sign in

SELLAS Life Sciences Group, Inc. (SLS)

Nasdaq: SLS · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2007
Full chart Alerts Compare
Grade4.4
◀ Past 1.8● Present 6.2▶ Future 4.5
4 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 19, 2026Mar 20, 2025Mar 28, 2024Mar 16, 2023Mar 31, 2022Mar 23, 2021Mar 13, 2020Mar 22, 2019Apr 13, 2018Mar 15, 2017
Revenue··01,0007,6001,9000···
For lenders
Net interest income··525317626118-266-462-1,166
Cost of revenue0001002000····
Research and development16,02219,09624,00720,26815,6749,2827,2858,7676,06719,860
Selling, general and administrative12,25212,41713,86212,58211,3209,6009,92312,77215,0894,593
Total operating expenses·········31,867
Total costs and expenses28,27431,51337,86942,95032,89418,88220,04131,08923,039·
Operating income-28,274-31,513-37,869-41,950-25,294-16,982-20,041·-23,039-15,988r
Interest income (expense), net1,411632525·······
Other income (expense), net·········5,047
Total non-operating income (expense)1,4116325296494,358208-19,373-29,048-23,50121,009
Income before income taxes-26,863-30,881-37,340-41,301-20,936-16,774-19,372-29,048-23,501-17,680
Income tax expense0000-237-17-81-1,3782531r
Income from continuing operations·····-16,757-19,292-27,670-23,754-11,101
Income from discontinued operations·········12,448
Net income-26,863-30,881-37,340-41,301-20,699-16,757-19,292-27,670-23,754-17,681r
Preferred dividends······04,4360·
Net income to common shareholders····-20,699-16,835-27,951-41,251-24,429-17,681
Earnings per share, basic-0.25-0.50-1.34-2.13-1.34-2.11····
Earnings per share, diluted-0.25-0.50-1.34-2.13-1.34-2.11····
Earnings per share, basic and diluted·····-2.11-10.92-157.72r-10.44-18.66r
Weighted average shares, basic109,051,21561,202,41227,777,11119,395,70915,481,1137,977,104····
Weighted average shares, diluted109,051,21561,202,41227,777,11119,395,70915,481,1137,977,104····
Weighted average shares, basic and diluted·····7,977,1042,558,755261,542r2,340,368947,401r
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Net interest income interest earned less interest paidus-gaap:InterestIncomeExpenseNet
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
us-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperations
Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Preferred dividends paid to preferred holders before common shareholdersus-gaap:PreferredStockDividendsIncomeStatementImpact
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton SLS · research, not advice